Glow Blend — Clinical Reference

**⚠ Educational reference only — not medical advice.** This article is for research and educational reference. Always consult your own physician before considering any peptide protocol. See the full Disclaimer at the end of this article. ## Introduction Glow Blend is a proprietary multi-peptide formulation marketed in research and aesthetic contexts for skin, hair, and connective-tissue endpoints. Composition is not standardized across suppliers; commonly cited components include GHK-Cu (a copper-binding tripeptide active in skin remodeling research), Melanotan II (a melanocortin agonist with documented tanning effect), and BPC-157 (a body-protection compound with broad tissue-repair research). ## Mechanism of Action Mechanisms depend on the constituent peptides. GHK-Cu binds copper, stimulates extracellular-matrix turnover, and modulates wound-healing pathways. Melanotan II activates melanocortin receptors (MC1R for pigmentation; MC3/4R for appetite and sexual function). BPC-157 acts on angiogenesis, growth-factor expression, and the nitric-oxide system. ## Research Indications Aesthetic and dermatologic endpoints: skin texture, fine lines, hair density, and pigmentation. No approved clinical indication exists for the blend as a finished product. ## Reconstitution Follow the **supplier-specific instructions** for the exact product you have purchased. General guidance for a multi-peptide blend in a **10 mg total-mass vial**: add **2 mL of bacteriostatic water**, swirl gently. Resulting concentration is **5 mg/mL of total peptide mass** — but the per-component concentration depends on the blend ratio, which varies by supplier. ## Dosing Protocol (research literature) Must be set by your supervising clinician against the **specific component breakdown** of your product. A typical aesthetic protocol cited for GHK-Cu-dominant blends is **100–300 mcg total subcutaneously daily**, often timed to evening for skin-remodeling cycles. Cycle length **8–16 weeks**, then 4-week off for reassessment. ## Administration Subcutaneous injection, rotating sites — abdominal fat or near the target area for skin/hair protocols where local effect is preferred. ## Storage & Handling Lyophilized: refrigerate (2–8°C). Reconstituted: refrigerate; stability depends on the most fragile component — typically **14–21 days**. Protect from light. Do not freeze. ## Side Effects Review each constituent's profile. Melanotan II carries appetite, blood-pressure, and pigmentation considerations and is associated with increased nevus formation in long-term use. GHK-Cu and BPC-157 are typically well-tolerated at the doses above. ## Contraindications Pregnancy, lactation, melanoma history, uncontrolled hypertension, atypical or dysplastic nevi. ## Monitoring Baseline blood pressure, full-body skin/nevus survey (especially with Melanotan II as a component), and the patient's stated aesthetic endpoint. Re-evaluate at 12 and 24 weeks. ## Disclaimer **This article is for informational and research-reference purposes only.** Nothing in this document constitutes medical advice, a prescription, or a recommendation from a physician. The reconstitution, dosing, and protocol information above reflects ranges commonly cited in published research and clinician-directed protocols — it is provided as reference material only, not as instructions, an endorsement of off-label use, or a substitute for individualized medical evaluation. **Customers should do their own research and consult their own physician** before considering any peptide protocol. Whether a given compound is appropriate for an individual — and at what dose, for what duration, and alongside what monitoring — is a decision that only a licensed clinician with knowledge of that individual's medical history, current medications, and conditions can make. The platform and the author make no claim that any compound described here is safe, effective, or appropriate for any particular person or purpose, and accept no responsibility for outcomes arising from self-directed use of the information.